Log in to save to my catalogue

In vitro binding evaluation of ¹⁷⁷Lu-AMBA, a novel ¹⁷⁷Lu-labeled GRP-R agonist for systemic radiothe...

In vitro binding evaluation of ¹⁷⁷Lu-AMBA, a novel ¹⁷⁷Lu-labeled GRP-R agonist for systemic radiothe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66917070

In vitro binding evaluation of ¹⁷⁷Lu-AMBA, a novel ¹⁷⁷Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues

About this item

Full title

In vitro binding evaluation of ¹⁷⁷Lu-AMBA, a novel ¹⁷⁷Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues

Publisher

Dordrecht: Dordrecht : Springer Netherlands

Journal title

Clinical & experimental metastasis, 2009, Vol.26 (2), p.105-119

Language

English

Formats

Publication information

Publisher

Dordrecht: Dordrecht : Springer Netherlands

More information

Scope and Contents

Contents

Members of the gastrin-releasing peptide (GRP) family and its analogs bombesin (BBN) have been implicated in the biology of several human cancers including prostate, breast, colon and lung. To date, three mammalian GRP/BBN receptor subtypes have been cloned and characterized: the neuromedin B receptor (NMBR), the GRP receptor (GRPR) and the BBN-rec...

Alternative Titles

Full title

In vitro binding evaluation of ¹⁷⁷Lu-AMBA, a novel ¹⁷⁷Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_66917070

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66917070

Other Identifiers

ISSN

0262-0898

E-ISSN

1573-7276

DOI

10.1007/s10585-008-9220-0

How to access this item